subsequent European groups, K14 also shares alleles with European Neolithic farmers and contemporary people from the Middle East/ Caucasus, which are not found in MA1 and western European MHGs, indicating genetic exchange between K14 and a Basal Eurasian Lineage (which eventually contributed to Neolithic groups) after the ancestors of MA1 and subsequent European MHGs had diverged. This implies that early AMH populations became structured early in their history, but in the UP already contained the major genetic components found in Europeans today. As such, our findings show the existence of a metapopulation structure in Europe from the Upper Paleolithic onward, remnants of which are still found today despite migrations to and from Europe since the UP. The early UP contribution is greater among northern than southern Europeans, in agreement with the southeast to west and north gene flow cline resulting from the expansion of Neolithic famers 9 to 6 ky cal B.P. (20, 45) . However, descendants of the early UP population represented by K14 likely also contributed genes to western Siberian groups living around the mouth of the Yenisei River. Therefore, our findings support the view that these Uralicspeaking populations represent an ancient admixture between European and East Asian lineages. The recently proposed Holocene gene flow from East Asians into northern Europeans (21) can, in our view, be equally well explained by population structure of the hunter-gatherer metapopulation within Europe. As such, our results paint an increasingly complex picture of colonization history of Europe from the UP to today. Instead of inferring a few discrete migration events from Asia into Europe, we now see evidence that humans in Western Eurasia formed a large metapopulation with gene flow in multiple directions occurring repeatedly and perhaps continuously.
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Tetanus neurotoxin (TeNT) is among the most poisonous substances on Earth and a major cause of neonatal death in nonvaccinated areas. TeNT targets the neuromuscular junction (NMJ) with high affinity, yet the nature of the TeNT receptor complex remains unknown. Here, we show that the presence of nidogens (also known as entactins) at the NMJ is the main determinant for TeNT binding. Inhibition of the TeNT-nidogen interaction by using small nidogen-derived peptides or genetic ablation of nidogens prevented the binding of TeNT to neurons and protected mice from TeNT-induced spastic paralysis. Our findings demonstrate the direct involvement of an extracellular matrix protein as a receptor for TeNT at the NMJ, paving the way for the development of therapeutics for the prevention of tetanus by targeting this protein-protein interaction.
T etanus neurotoxin (TeNT) is composed of two subunits, which perform specific functions necessary for targeting this toxin to the central nervous system (CNS) and its high potency. The heavy (H) chain mediates high-affinity binding and entry into neurons, whereas the light (L) chain causes synaptic silencing of inhibitory interneurons, which normally suppress motor neuron activity, and thereby induces spastic paralysis (1) . After internalization into motor neurons, TeNT and the carboxylterminal fragment of its H chain (H C T) are sorted to signaling endosomes, which undergo axonal retrograde transport toward the motor neuron cell body (2) . We have previously characterized the proteome of these organelles using H C T-conjugated magnetic nanoparticles (2) . This affinity purification approach identified a list of proteins associated with signaling endosomes, some of which were predicted to be involved in the binding and/or internalization of H C T. We analyzed the sequences of these proteins for the presence of the tripeptide Tyr-Glu-Trp (YEW), which was previously shown to interact with the sialic acid binding site (R site) of H C T, a region implicated in polysialoganglioside and acidic lipid binding (3, 4) . The corresponding region of botulinum neurotoxins (BoNTs) interacts with the synaptic proteins SV2A-C or synaptotagmin I/II (5-11), raising the possibility that the R site of TeNT also binds to a protein receptor.
To identify putative TeNT receptors, we selected candidates containing variants of the YEW peptide, where this motif is present within the lumen of signaling endosomes, a localization topologically equivalent to the extracellular domain of these proteins when localized to the plasma membrane (table S1). A total of 35 nineresidue peptides containing the YEW motif or closely related sequences were tested for binding to H C T by using direct fluorescent binding, enzyme-linked immunosorbent assay (ELISA), and peptide pull-down assays (Fig. 1A and fig.  S1 , A and B). The interacting peptides were then assessed for their ability to compete for H C T SCIENCE sciencemag.org 28 The percentage of maximal binding was plotted for each peptide. The results were tested for significance between individual peptides and Tris-buffered saline (TBS) control (n = 3 independent experiments; *P < 0.05; error bar, SD). (B) Pull-down of HA-H C T preincubated with full-length recombinant nidogen-1 (top) or nidogen-2 (bottom). "Empty beads" corresponds to samples in which HA-H C T was omitted, and "DMSO" (dimethyl sulfoxide) to samples treated with vehicle control. Both nidogen-1 and -2 bind directly to HA-H C T, and pretreatment with the N1 or N2 peptide blocks this interaction. In contrast, mutant peptides (N1 AA and N2 AA ) are ineffective in preventing this interaction (n = 3 independent experiments for both proteins). The bands detected in the empty bead controls are due to the heavy chain of the capture antibody, which comigrates with H C T. (C and E) Vehicle control (H C T alone), N1, or N1 AA peptides were (C) preincubated, (E) added together (0 min), or added after a 10-min delay (10 min) to primary mouse motor neurons treated with AlexaFluor555-H C T in the absence or the presence of exogenous nidogen-1 (C) before fixing, immunostaining for bIII tubulin, and imaging. Scale bar, (C) 50 mm; (E) 10 mm. (D and F) Quantification of the data shown in (C) and (E). Twenty images (D) or three-tile scans of 4 by 4 fields (F) were taken for each condition, and fluorescence intensity of AlexaFluor555-H C T bound to neurons as defined by a bIII tubulin mask was quantified. Results were tested for statistical significance (n = 3 independent experiments; NS, nonsignificant; **P < 0.01; ***P < 0.005; ****P < 0.001; error bar, SD).
binding on primary motor neurons ( fig. S1C ). Peptides N1 and N2, which correspond to short sequences in nidogen-1 and nidogen-2, respectively (table S1 and fig. S1D ), were selected for further investigation because they significantly reduced H C T binding to neurons (Fig. 1 , C and D, and fig. S1C ). The YEW-like motif of nidogen-1 (YQW) and nidogen-2 (WSY) and their flanking residues were responsible for this interaction because single alanine mutants showed reduced binding to H C T (fig. S1, E and F), and the double alanine mutant (N1 AA ) (table S1) failed to block the binding of H C T to motor neurons (Fig. 1, C and D). Furthermore, when the N1 peptide, but not N1 AA , was added to motor neurons, either together with H C T or 10 min afterwards, it still significantly inhibited H C T binding to these neurons ( Fig. 1 , E and F).
We then tested whether H C T interacts directly with full-length nidogens by incubating immobilized hemagglutinin (HA)-tagged H C T with fulllength recombinant nidogen-1 or nidogen-2 and demonstrated that both proteins directly bind to H C T (Fig. 1B) . The N1 and N2 peptide sequences of nidogen-1 and -2 played a key role in this interaction because preincubating H C T with an excess of these peptides, but not their respective mutants (table S1), abolished this binding (Fig. 1B) .
The two mammalian nidogens play partially overlapping roles in basement membrane (BM) formation and maintenance (12) (13) (14) . Although nidogen-2 knockout (KO) mice do not display any overt phenotype, animals lacking nidogen-1 develop a progressive hindlimb paralysis, indicating a role for this protein in motor neuron survival (15) . Nidogens are tightly integrated within the BM, which renders them difficult to access for exogenous ligands. To determine whether the amount of cell surface-associated nidogens is the limiting factor for H C T binding to motor neurons, we added soluble full-length nidogen-1 together with H C T to cultured motor neurons. This resulted in the binding of exogenous nidogen-1 to motor neurons ( fig. S2 ) and augmented the amount of cell surface-bound H C T (Fig. 1, C and D) , suggesting that the addition of exogenous nidogen-1 increased the number of H C T binding sites on the neuronal surface. This effect was dependent on the YEW-like motif of nidogen-1 because preincubation of H C T with the N1 but not the N1 AA peptide prevented the increased cell surface binding of H C T (Fig. 1, C and D ). Coimmunoprecipitation of H C T and endogenous nidogen-2 from motor neurons incubated with H C T for 5 min at 37°C ( fig. S3 ) suggested that the interaction between nidogens and H C T is preserved upon entry of H C T into endosomal compartments.
Inspection of the domain structure of nidogens revealed that the N1 and N2 peptides reside within the globular G 2 domain ( fig. S4A and movie S1). Molecular modeling ( fig. S4 , B to D) revealed that the N1 peptide, both in isolation and within the intact G 2 domain, is able to dock to the R site of H C T, where sialic acid, disialyllactose, and the YEW motif bind (4). The molecular surface concealed by the N1 peptide-H C T complex constitutes more than 40% of the total peptide surface ( fig. S4C ), suggesting that this interaction, which is driven by the potential formation of five hydrogen bonds and other polar interactions (table S2) , is very strong.
The G2 domain of nidogen-1 fits into a large crevice at the top of the trefoil domain of H C T ( fig. S4B and movie S1), concealing 1114 Å 2 and 1106 Å 2 of the molecular surface of H C T and the G2 domain of nidogen-1, respectively. Complex formation is likely to be promoted by complementary electrostatic surfaces and several potential hydrogen bonds (table S3 and fig. S4D ). To confirm the validity of this structural model, we mutated several residues of the R site of H C T that are predicted to play an important role in the formation of this complex. As shown in fig. S5 , we found that mutations of R1226, T1146, and Y1229, which form potential H-bonds with nidogen-1 (tables S2 and S3, respectively), as well as of other R site residues (P1212 and G1215) (16) , reduced the binding of both N1 and N2 peptides. Similarly, alanine scanning of the YEW-like motif and flanking residues in the N1 and N2 peptides strongly decreased their interaction with H C T ( fig. S1 , D to F), which strongly supported the validity of the model shown in fig. S4 . This mode of interaction is likely to be conserved through evolution because the human N1 and N2 peptides show a high degree of homology to the corresponding mouse sequences and also bound H C T ( fig. S1D) . Crucially, this model predicts that the association between H C T and nidogen-1 is unlikely to interfere with the interaction between H C T and polysialogangliosides, which is required for TeNT binding to the neuronal surface (3, 17) . Thus, nidogens and polysialogangliosides have the potential to bind TeNT simultaneously and thereby fulfill the requirements for the proposed dual receptor model (18, 19) , which predicts the concurrent interaction of lipid and protein receptors with TeNT and BoNTs for their high-affinity binding to neuronal membranes.
Nidogen-2 is highly enriched at the NMJ (20), and we sought to investigate whether it is localized to the specialized presynaptic BM of this structure. We thus injected the lower hindlimb of wild-type mice with H C T and then immunostained cryosections of the extensor digitorum longus (EDL) muscle for choline acetyltransferase (ChAT), a motor neuron marker, and nidogen-2. This analysis revealed that H C T binds to the presynaptic motor neuron nerve terminal, which is in close apposition to the postsynaptic acetylcholine receptor, labeled by a-bungarotoxin (a-BTx) ( Fig. 2A) . Increased H C T binding was detected in areas where nidogen-2 was most abundant (Fig.  2B and movie S2 ) and was absent from NMJs that did not express nidogen-2, which revealed a strong correlation between the nidogen-2 content and H C T binding at the NMJ (Fig. 2C) . We then assessed whether these two proteins are internalized and transported together in signaling endosomes. H C T and an antibody against nidogen-2 were added to primary motor neurons at 37°C and allowed to internalize. After a mild acid wash to remove all probes still bound to the neuronal surface, the internalized a-nidogen-2 was detected by using a fluorescently tagged secondary antibody. The extensive colocalization between a-nidogen-2 and H C T throughout the axonal network and cell bodies (66%) strongly indicated that these two proteins were internalized together and cotransported by the same organelles (Fig. 2D) .
To further test the importance of nidogens in TeNT intoxication, we determined the susceptibility of nidogen KO mice to TeNT-induced paralysis and assessed the ability of H C T to bind neurons and tissues derived from these mice. Compared with wild-type motor neurons, nidogen-2 KO motor neurons exhibited a significantly reduced ability to bind H C T in vitro (Fig. 3, A and  B) . This was further verified in vivo by demonstrating that NMJ uptake of H C T was severely impaired in levator auris longus (LAL) muscles isolated from both nidogen-1 and nidogen-2 KO mice (Fig. 3, C and D) . In stark contrast, the capacity of the corresponding binding fragment of BoNT/A (H C A) to bind to nidogen null NMJ was largely unaffected (fig. S6A) . Crucially, the addition of full-length recombinant nidogen-1 restored the ability of H C T to bind NMJs lacking nidogen-1 ( fig. S6B ). This rescue was determined by the recruitment of recombinant nidogen-1 to mutant NMJs ( fig. S6B) , suggesting a replenishment of H C T acceptor sites at the synaptic cleft.
In the genetic background used in our experiment, nidogen-1 and -2 double knockout (DKO) mice show early embryonic lethality (21), precluding the derivation of motor neuron cultures. To overcome this limitation, we assayed H C T uptake into isolated hindbrains of DKO embryos taken at embryonic day 11.5 (E11.5). In contrast to control hindbrains, which displayed robust H C T staining, hindbrains from DKO littermates were unable to bind H C T (Fig. 3E) , further indicating that nidogen-1 and -2 are essential for H C T binding in vivo (Fig. 3F) .
Because the N1 peptide inhibited H C T binding to NMJs in whole LAL muscle preparations (Fig.  4A) , we investigated the ability of the N1 peptide to prevent uptake of TeNT in vivo, using three independent assays. First, full-length TeNT was injected locally into the triceps surae muscle either alone or in combination with the N1 or N1 AA peptides, and the effect on spastic paralysis was assessed in vivo by means of footprint analysis 24 hours after injection (Fig. 4, B Motor neurons derived from E13.5 wild-type and nidogen-2 knockout (KO) mouse embryos were incubated with HA-H C T (gray). Cells were fixed and stained for HA-H C T, and fluorescence intensity was quantified in 14 images by using a bIII tubulin mask (green). Scale bar, 20 mm. The value of nontreated cells was subtracted, and data were analyzed [(B), n = 3 experiments-shown is a representative experiment; ****P < 0.001; error bar, SD]. (C) LAL muscles of wild-type, and nidogen-1 and -2 KO animals were incubated with HA-H C T, fixed, and stained for HA (gray) and a-BTx (green) to identify NMJs. Scale bar, 5 mm. (D) Both nidogen-1 and -2 KO NMJs show a significant decrease in their ability to bind and internalize H C T (n = 3 animals per group, 20 images per animal; ****P < 0.001; error bar, SD). (E) Nidogen-1 and -2 DKO and wild-type E11.5 embryonic hindbrains were tested for H C T binding and uptake. Scale bar, 1 mm. (F) Mean intensity of H C T staining was measured and analyzed for significance (n = 3 animals per group; *P < 0.05; error bar, SD). abnormalities, with the characteristic inability to place the affected hindpaw in the former position of the ipsilateral forepaw, as occurs in normal mice (Fig. 4, B and C) . At a later stage, TeNT caused a permanent plantar-flexion of the affected hindpaw (movie S3). Coadministration of the N1 peptide completely abolished these TeNTinduced gait abnormalities (movie S3), whereas the N1 AA peptide was ineffective (Fig. 4, B and C) .
To corroborate this finding, we quantified the protective effect of the N1 peptide by co-injecting it with TeNT and measuring the maximal force generated by the tibialis anterior (TA) muscle using in vivo isometric muscle tension physiology. The contractile force of the TeNT-injected muscle was diminished (3.11 T 0.88% of noninjected control) (Fig. 4D and fig. S7A ), as was the case for muscles co-injected with TeNT and the N1 AA peptide (2.14 T 1.44% of noninjected control) (Fig. 4D and fig. S7B ). In contrast, coadministration of the N1 peptide significantly abrogated the TeNT-mediated decline in contractile force compared with that of the other two groups (47.46 T 10.31% of noninjected control) ( Fig. 4D and fig. S7C ). Similar results were obtained by using phrenic nerve-hemidiaphragm preparations ( fig. S7D) (22) . Together, these results confirmed the ability of the N1 peptide to prevent symptoms of tetanus in vivo.
In order to assess the susceptibility of nidogen-2 KO mice to systemic TeNT toxicity in vivo, we injected wild-type and nidogen-2 KO mice intraperitoneally with different doses of TeNT and monitored the appearance of tetanus. Nidogen-2 KO animals showed a significant delay in the onset and progression of tetanic symptoms at lower TeNT doses (Fig. 4E) . Unfortunately, the possibility to extend these assays to mice lacking nidogen-1 was precluded by the severe epileptic and paralytic phenotype affecting these animals (15) .
Some of the symptoms displayed by nidogen-2 KO mice injected with TeNT, such as keratoconjuctivitis sicca (23) , resembled those of botulism. This suggests that in the absence of one of its physiological receptors, a proportion of TeNT may exploit alternative routes of entry at the NMJ, which are shared with BoNTs. Crosstalk between the two modes of entry and intracellular transport pathways taken by TeNT and BoNTs has been previously suggested (24) and is further supported by the botulism-like symptoms shown by mice injected with high doses of TeNT (25) .
Because BoNTs use several SV2 isoforms as receptors (9) (10) (11) 22) and SV2A has been proposed as a TeNT receptor in central neurons (26), we quantified the colocalization of H C T with SV2A and SV2C in motor neurons and tested whether preincubation of H C T with recombinant nidogen-1 modifies the association of H C T with these synaptic vesicle proteins. In the absence of exogenous nidogen, SV2A showed robust colocalization with H C T internalized for 45 min at 37°C (46%) (fig. S8, A and B ), whereas the codistribution of H C T with SV2C under these conditions was relatively low (fig. S8, C and D) . Therefore, at least a subpool of TeNT may be internalized via synaptic vesicle recycling at the relatively high concentrations used in this assay. However, the addition of recombinant nidogen-1 caused a significant reduction in the colocalization of H C T with SV2A (22%) (fig. S8, A and  B) but not with SV2C ( fig. S8, C and D) . However, despite the addition of recombinant nidogen-1 causing an increased intracellular pool of HcT, the proportion of this probe colocalizing with SV2A was significantly reduced (fig. S8, A and B) . Taken together, these data suggest that in the presence of nidogen-1, H C T is preferentially targeted to an endocytic pathway linked to axonal retrograde transport to the cell body and is not taken up by synaptic vesicle recycling.
We have identified the protein receptor responsible for TeNT binding and internalization at the NMJ as well as a potential mechanism to explain the overlap between the entry routes of TeNT and BoNTs ( fig. S9 ). Engineered growth factors with higher affinity for the extracellular matrix (ECM) display enhanced biological activity (27) , indicating that differential binding of such ligands to ECM components is crucial for their signaling and biological function (28). TeNT (A) LAL muscles were incubated with HA-H C T, which had been pretreated either with vehicle control (H C T alone), the N1 peptide, or the N1 AA mutant in motor neuron culture medium. Muscles were then immunostained for HA and a-BTx to identify NMJs. The ratio of H C T-positive to HcT-negative NMJs was quantified and analyzed for significance (n = 3 independent experiments, six images per condition; NS, nonsignificant; **P < 0.01; error bar, SD). (B) Footprint analysis of control mice, or of mice after injection into the triceps surae muscle of a sublethal dose of TeNT, or TeNT preincubated with the N1 AA or N1 peptides. Black circles show the paw prints from the noninjected left hindlimb and right frontlimb, and red circles mark the paw print of the TeNTinjected right hindlimb. In control and TeNT+N1-injected mice, the black and red circles overlap, whereas in TeNT-and TeNT+N1 AA -injected mice, they are separated, indicating impairment in coordination due to local tetanus. (C) The distance between the paw prints on the injected side was measured and tested for statistical significance (n = 2 independent experiments; data from two animals are shown; NS, nonsignificant; *p < 0.05; **p < 0.01; error bar, SD). (D) The TA muscle was injected with TeNT preincubated with either DMSO (vehicle control), N1 AA , or N1 peptides. After anesthesia, the tendon of this muscle was attached to a tension sensor, and the peroneal nerve was stimulated. Maximal muscle force was measured, normalized to muscle weight, and tested for statistical significance in control versus injected muscle. The N1-treated group retained a significantly higher muscle force than that of the vehicle-or N1 AA -treated groups. (n = 6 mice per group; **P < 0.01; error bar, SEM). (E) Age-and weight-matched nidogen-2 KO and wild-type mice were injected intraperitoneally with TeNT and monitored for up to 96 hours. The time of termination due to loss of righting reflex was plotted against the TeNT dose. Generalized tetanus in nidogen-2 KO animals was delayed at lower doses (1.5 ng/kg) compared with that in wild-type controls (n = 2 experiments, minimum two mice per group; **P < 0.01; error bar, SD).
might exploit a similar strategy based on a very efficient capture mechanism at specialized NMJ sites rich in nidogens, which may function to concentrate TeNT as well as physiological ligands, such as neurotrophic factors, to facilitate their uptake and sorting to axonal transport organelles. At these sites, TeNT in complex with nidogens may interact with surface receptors known to bind nidogens, such as the protein phosphatase LAR (29, 30) . This specialized capture mechanism is likely to be indispensable to the host cell, and this enables TeNT to be lethal at extremely low concentrations. Our study suggests that nidogens are prime therapeutic targets for suppressing the uptake of TeNT at the NMJ and its access to the CNS, preventing its lethal effects.
